The landscape of oral SERDs and their potential in ER+ breast cancer Published 2024-02-08 Download video MP4 360p Recommendations 07:59 What are CDK 4/6 Inhibitors for Breast Cancer? 20:37 GS2-02: "Elacestrant, an oral selective estrogen receptor degrader (SERD), vs investigator’s..." 03:59 Introduction to Cancer Biology (Part 4): Angiogenesis 05:47 Are gifted children getting lost in the shuffle? 02:02 Hormone Therapy for Breast Cancer 06:02 Ductal carcinoma in situ, are we over-treating it? 07:33 3 or 6 months adjuvant oxaliplatin for colorectal cancer 05:57 SABCS 2023 | Wir brauchen mehr BRCA -Testungen zur Therapieentscheidung bei Brustkrebs. 05:54 Oral SERDS: New endocrine therapy options in ER+ metastatic breast cancer - a patient case video 06:35 My Breast Cancer Story 01:07 Estrogen receptor antagonists - Fulvestrant 05:16 Adjuvant treatment for colon cancer: How to treat a stage III colon cancer? 11:11 Beyond the Lab: Molly Seale (Medical Science Liaison) 12:21 Top 10 Highest Paying Healthcare Jobs 00:46 Watch me have my Faslodex bum injections #breastcancer 10:55 What is low-grade non-Hodgkin lymphoma? 03:37 Hydroxyurea Treatment for Children with Sickle Cell Disease 18:40 Overview of Clinical Data of SERDs & Their Place in Treatment Landscape 28:48 Management and Treatment of Ductal Carcinoma in Situ (DCIS) 22:53 Chemotherapy for Appendix Cancer, The Old and New: Dr. Ardaman Shergill, Oncologist, U Chicago Similar videos 57:18 Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer 1:16:18 SERDs at the Inflection Point in Pretreated ER+/HER2- Breast Cancer: Novel ER-Targeting Therapies 59:38 What's New and on the Horizon for Metastatic Breast Cancer? 59:39 ER-Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019 37:53 Addressing the Challenge of Endocrine-Resistant Breast Cancer 09:44 Navigating ER+ metastatic breast cancer: Explore a patient case 1:19:57 Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer 34:06 The emerging role of SERD's in HR+ breast cancer 14:24 Optimisation of Treatment Selection & Sequencing Decisions in ER+/HER2- Breast Cancer 1:03:35 The Impact of Targeted Estrogen Receptor (ER) Imaging on Breast Cancer Patients 3:37:30 The 2023 OncoAlert Colloquium (Breast Cancer) 1:19:57 Oncology Today with Dr Neil Love: Overcoming Endocrine Resistance in ER-Positive Metastatic Breas... 57:25 Drs. Bardia, Hurvitz, & Spring talk #BreastCancer during #ASCO22 - https://bit.ly/3tVN82X 59:56 Research Update on Metastatic Breast Cancer 2:17:54 Changing Treatment Landscape In HR+HER2 aBC More results